Milestone Scientific, Inc.
220 S. Orange Avenue
Livingston
New Jersey
07039
United States
Tel: 973-535-2717
Fax: 973-535-2829
Website: http://www.milesci.com/
Email: Info@MileSci.com
235 articles about Milestone Scientific, Inc.
-
Milestone Scientific Expands Medical Indications for the CompuFlo® Epidural Instrument and Commences Disposable Sales to a Leading Veterinary and Academic Institution
5/27/2022
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today reported that it has commenced sales of its CompuFlo ® Epidural instrument disposables at a leading veterinary and academic institution following a successful research study and evaluation.
-
Milestone Scientific Announces the Appointment of Retail Industry Veteran Ms. Benedetta Casamento to its Board of Directors
5/23/2022
Milestone Scientific Inc., a leading developer of computerized drug delivery instruments that provide painless and precise injections, announced the appointment of Ms. Benedetta Casamento to the Company’s Board of Directors.
-
Milestone Scientific Achieves Revenue of $2.7 Million and Provides Business Update for the First Quarter of 2022
5/17/2022
Milestone Scientific Inc. provided a business update and announced financial results for the first quarter ended March 31, 2022.
-
Milestone Scientific Schedules First Quarter 2022 Financial Results and Business Update Conference Call
5/13/2022
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Tuesday, May 17, 2022, to discuss the company’s financial results for the first quarter ended March 31, 2022.
-
Milestone Scientific Commences Sales of CompuFlo® Epidural / CathCheck™ Verification System Disposables to a Premier Northeast Hospital
4/11/2022
Milestone Scientific Inc. reported that, following a successful trial and evaluation, it has commenced sales of its CompuFlo® Epidural and CathCheck™ Verification System disposables to a leading northeast medical center.
-
Milestone Scientific Reports 90% Year-Over-Year Revenue Growth and Provides 2021 Year-End Business Update
4/1/2022
Milestone Scientific Inc., a leading developer of computerized drug delivery instruments that provide painless and precise injections, provided a business update and announced financial results for the full year ending December 31, 2021.
-
Milestone Scientific Schedules 2021 Fiscal Year Financial Results and Business Update Conference Call
3/29/2022
Milestone Scientific Inc. today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, April 1, 2022 to discuss the company’s financial results for the 2021 fiscal year ended December 31, 2021, as well as the company’s corporate progress and other developments.
-
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Two Premier Pain Clinics
3/29/2022
Milestone Scientific Inc. today announced that it has commenced sales of the CompuFlo ® Epidural disposables at the Cypress Surgery Center in Santa Maria, California and the Galileo Surgery Center in San Luis Obispo.
-
Milestone Scientific CEO to Participate in Fireside Chat Hosted by Maxim Group and M-Vest on January 20th
1/18/2022
Milestone Scientific Inc., a leading developer of computerized drug delivery instruments, that provide virtually painless and precise injections, announced that Arjan Haverhals, CEO and president of Milestone Scientific, will participate in a virtual fireside chat hosted by Anthony Vendetti, executive managing director of research at Maxim Group LLC.
-
Milestone Scientific Projects Revenue to Increase Over 85% to More than $10 Million for 2021
1/10/2022
Milestone Scientific Inc. today provided revenue guidance for the fourth quarter and year ended December 31, 2021.
-
Milestone Scientific to Present at the H.C. Wainwright BioConnect 2022 Conference
1/7/2022
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that Arjan Haverhals, Chief Executive Officer of Milestone Scientific, will be presenting at the H.C. Wainwright BioConnect 2022 Conference being held virtually January 10-13, 2022.
-
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Prominent Pain Clinic with Leading Physician
1/6/2022
Milestone Scientific Inc today announced that Dr. Harsh Govil, MD, MPH, whose practice is based in Statesville, NC, has begun incorporating the CompuFlo ® Epidural instrument into his practice for pain management, following a successful evaluation.
-
Milestone Scientific Announces Purchase of CompuFlo / CathCheck™ Verification System Disposables at Two Additional Premier HospitalsBoth hospitals belong to large hospital systems representing future growth opportunities
12/28/2021
Milestone Scientific Inc. today announced the purchase of its CompuFlo ® Epidural and CathCheck ™ Verification System disposables from two additional leading hospitals, expanding the Company’s geographic footprint.
-
Milestone Scientific Names Andau Medical as an Additional Distributor for the STA Single Tooth Anesthesia System® in North America
12/23/2021
Milestone Scientific Inc. today announced it has entered into an agreement with Andau Medical to distribute the STA Single Tooth Anesthesia System ® in the United States and Canada.
-
Milestone Scientific Announces Purchase Agreement for its CompuFlo® Epidural / CathCheck™ Verification System Disposables with a Premier Northeast Teaching Hospital
12/22/2021
Milestone Scientific Inc. today reported, that following a successful trial, it has signed an agreement for the purchase of its CompuFlo ® Epidural and CathCheck ™ Verification System disposables with a major Northeast teaching hospital, which is part of one of the leading health systems in the United States.
-
Milestone Scientific CEO Arjan Haverhals to Participate in the Benzinga All Access Event on December 16th
12/15/2021
Milestone Scientific Inc., a leading developer of computerized drug delivery instruments, that provide painless and precise injections, announced that Arjan Haverhals, Chief Executive Officer and President of Milestone Scientific, will be participating in the Benzinga All Access event taking place on December 16, 2021.
-
Dr. Miguel de la Garza, President of the Florida Society of Interventional Pain Physicians and Renowned Physician at Surgery Partners, Adopts Milestone Scientific’s CompuFlo® Epidural Instrument for Pain Management
12/1/2021
Milestone Scientific Inc., a leading developer of computerized drug delivery instruments, that provide painless and precise injections, announced that Dr. Miguel de la Garza has begun incorporating the CompuFlo® Epidural instrument into his practice for pain management, following approval by Surgery Partners, one of the largest and growing surgical services business in the country.
-
Milestone Scientific Reports 69% Increase in Revenue for Third Quarter of 2021
11/15/2021
Milestone Scientific Inc., a leading developer of computerized drug delivery instruments that provide painless and precise injections, provided a business update and announced financial results for the third quarter ended September 30, 2021.
-
Milestone Scientific Schedules Third Quarter 2021 Business Update Conference Call
11/11/2021
Milestone Scientific Inc. today announced it will host a conference call at 11:00 A.M. Eastern Time on Monday, November 15, 2021 to discuss the Company’s financial results for the third quarter ended September 30, 2021, as well as the Company’s corporate progress and other developments.
-
Milestone Scientific to Present at Dawson James Securities 6th Annual Small Cap Growth Conference on October 21, 2021
10/18/2021
Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that Arjan Haverhals, Chief Executive Officer and President of Milestone Scientific, will present at the Dawson James Securities Small Cap Growth Conference.